Establishment Labs Holdings Inc. (ESTA)
Market Cap | 1.18B |
Revenue (ttm) | 155.79M |
Net Income (ttm) | -82.76M |
Shares Out | 27.51M |
EPS (ttm) | -3.14 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 240,058 |
Open | 44.03 |
Previous Close | 43.34 |
Day's Range | 42.53 - 44.03 |
52-Week Range | 16.96 - 73.00 |
Beta | 1.22 |
Analysts | Buy |
Price Target | 56.67 (+32.56%) |
Earnings Date | Aug 6, 2024 |
About ESTA
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in... [Read more]
Financial Performance
In 2023, ESTA's revenue was $165.15 million, an increase of 2.13% compared to the previous year's $161.70 million. Losses were -$78.50 million, 4.38% more than in 2022.
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for ESTA stock is "Buy." The 12-month stock price forecast is $56.67, which is an increase of 32.56% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/9/u/press9-2445252.jpg)
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/k/9/press18-2421702.jpg)
Establishment Labs Reports First Quarter 2024 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/z/w/press7-2406023.jpg)
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/t/k/press1-2402696.jpg)
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/a/m/conf8-2387961.jpg)
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/p/n/press11-2375715.jpg)
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/f/f/press15-2299581.jpg)
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/c/w/press17-2288293.jpg)
Establishment Labs Announces Amended Credit Facility with Oaktree
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, today ...
![](https://cdn.snapi.dev/images/v1/w/w/conf16-2275622.jpg)
Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/b/f/press13-2238200.jpg)
Establishment Labs Announces Commercial Launch of Motiva Implants in China
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/g/e/press12-2222164.jpg)
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA) (“Establishment Labs” or the “Company”), a global medical technology company dedicated to improving women's health and wellne...
![](https://cdn.snapi.dev/images/v1/a/y/press20-2213094.jpg)
Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/w/7/conf20-2210013.jpg)
Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/p/t/press2-2149591.jpg)
Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/i/q/press6-2145127.jpg)
Establishment Labs Reports Third Quarter 2023 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/s/u/conf3-2119524.jpg)
Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/p/1/press1-2104074.jpg)
Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/r/q/press8-2102354.jpg)
Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/j/i/press17-2012998.jpg)
Establishment Labs Reports Record Second Quarter 2023 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/i/p/conf18-1988733.jpg)
Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/x/0/press5-1977739.jpg)
Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded Capabilities
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/p/m/conf7-1914064.jpg)
Establishment Labs to Participate in Two Upcoming Investor Conferences
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/o/f/press7-1912013.jpg)
Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical Tools
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/q/c/press3-1877760.jpg)
Establishment Labs Reports Record First Quarter 2023 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and...
![](https://cdn.snapi.dev/images/v1/u/c/press1-1858257.jpg)
Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters' Option to Purchase Additional Shares
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (Nasdaq: ESTA) (the “Company”), a global medical technology company dedicated to improving women's health and wellness, principally in breas...